| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CELLECTAR BIOSCIENCES INC | 52,999 | 13,000 | 0.00% | ||
| 2 | PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | 114,000 | 0.01% | ||
| 3 | CELLECTAR BIOSCIENCES IN | 53,649 | 145,000 | 0.02% | ||
| 4 | APPLIED GENETIC TECHNOL CORP | 17,321 | 169,000 | 0.02% | ||
| 5 | ADAPTIMMUNE THERAPEUTICS PLC | 25,307 | 178,000 | 0.02% | ||
| 6 | ONCOBIOLOGICS INC - WARRANT A | 416,666 | 199,000 | 0.02% | ||
| 7 | PROVECTUS | 2,226,961 | 221,000 | 0.02% | ||
| 8 | NEOS THERAPEUTICS INC COM | 50,613 | 333,000 | 0.04% | ||
| 9 | GENVEC INC | 1,015,685 | 468,000 | 0.05% | ||
| 10 | HTG Molecular Diagnostics Inc | 203,464 | 472,000 | 0.05% | ||
| 11 | ONCOBIOLOGICS INC - WARRANT B | 416,666 | 500,000 | 0.06% | ||
| 12 | THRESHOLD PHARMACEUTICAL INC | 1,012,255 | 686,000 | 0.08% | ||
| 13 | NANOSTRING TECHNOLOGIES INC | 40,490 | 809,000 | 0.09% | ||
| 14 | AVEO PHARMACEUTICALS INC | 1,087,715 | 968,000 | 0.11% | ||
| 15 | AMICUS THERAPEUTICS INC COM | 151,838 | 1,124,000 | 0.12% | ||
| 16 | Ascendis Pharma | 62,254 | 1,251,000 | 0.14% | ||
| 17 | EPIZYME INC COM | 159,513 | 1,570,000 | 0.17% | ||
| 18 | CELYAD SA | 75,920 | 1,791,000 | 0.20% | ||
| 19 | AQUINOX PHARMACEUTICALS INC | 151,838 | 2,029,000 | 0.22% | ||
| 20 | GLYCOMIMETICS INC | 287,031 | 2,052,000 | 0.23% | ||
| 21 | REGENXBIO INC COM | 156,741 | 2,196,000 | 0.24% | ||
| 22 | APTOSE BIOSCIENCES INC | 990,579 | 2,229,000 | 0.25% | ||
| 23 | IMMUNE DESIGN CORP | 432,990 | 3,282,000 | 0.36% | ||
| 24 | LIPOCINE INC NEW | 751,296 | 3,351,000 | 0.37% | ||
| 25 | CORVUS PHARMACEUTICALS INC COM | 214,132 | 3,522,000 | 0.39% | ||
| 26 | Syndax Pharmaceuticals Inc | 240,403 | 3,645,000 | 0.40% | ||
| 27 | Agile Therapeutics, Inc. | 563,880 | 3,936,000 | 0.43% | ||
| 28 | Atara Biotherapeutics Inc | 186,460 | 3,988,000 | 0.44% | ||
| 29 | LION BIOTECHNOLOGIES INC COM | 505,941 | 4,164,000 | 0.46% | ||
| 30 | RIGEL PHARMACEUTICAL INC | 1,155,600 | 4,241,000 | 0.47% | ||
| 31 | ONCOBIOLOGICS INC | 1,027,216 | 4,366,000 | 0.48% | ||
| 32 | ACCELERON PHARMA INC | 127,451 | 4,612,000 | 0.51% | ||
| 33 | INTEC PHARMA LTD JERUSALEM | 809,804 | 4,762,000 | 0.53% | ||
| 34 | Catabasis Pharmaceuticals Inc | 800,000 | 4,928,000 | 0.54% | ||
| 35 | AVEXIS INC COM | 131,858 | 5,434,000 | 0.60% | ||
| 36 | PFENEX INC COM | 632,559 | 5,661,000 | 0.62% | ||
| 37 | DERMIRA INC COM | 172,083 | 5,820,000 | 0.64% | ||
| 38 | CYTOMX THERAPEUTICS INC COM | 371,636 | 5,827,000 | 0.64% | ||
| 39 | SOCIETAL CDMO INC | 669,239 | 5,916,000 | 0.65% | ||
| 40 | ZYNERBA PHARMACEUTICALS INC | 480,501 | 6,271,000 | 0.69% | ||
| 41 | Curis, Inc | 2,410,900 | 6,292,000 | 0.69% | ||
| 42 | SANGAMO THERAPEUTICS INCORPORATED | 1,402,331 | 6,493,000 | 0.72% | ||
| 43 | FORWARD PHARMA A/S | 339,175 | 7,123,000 | 0.79% | ||
| 44 | FULGENT GENETICS INC | 800,000 | 7,376,000 | 0.81% | ||
| 45 | ARRAY BIOPHARMA INC | 1,150,000 | 7,763,000 | 0.86% | ||
| 46 | ULTRAGENYX PHARMACEUTICAL INC COM | 110,842 | 7,863,000 | 0.87% | ||
| 47 | EMERGENT BIOSOLUTIONS INC | 250,000 | 7,883,000 | 0.87% | ||
| 48 | Audentes Therapeutics, Inc. | 449,660 | 8,008,000 | 0.88% | ||
| 49 | ACHILLION PHARMACEUTICALS IN | 1,006,128 | 8,150,000 | 0.90% | ||
| 50 | ALNYLAM PHARMACEUTICALS INC | 126,120 | 8,548,000 | 0.94% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001583977-16-000008, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
